Treatment adherence in COPD and asthma

Asthma and COPD are two of the most common long-term conditions in the world affecting over 339 million and 212 million people worldwide respectively. While there are effective treatments available to manage asthma and COPD, including bronchodilators and anti-inflammatory medications, these need to be used correctly and appropriately to have a maximal therapeutic effect. However, adherence to these medications has traditionally been poor due to several interrelated factors. Poor adherence is associated with reduced quality of life, poor clinical outcomes, higher mortality, and high healthcare and societal costs.